345 related articles for article (PubMed ID: 22173093)
21. Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro.
Aldinucci D; Lorenzon D; Stefani L; Giovagnini L; Colombatti A; Fregona D
Anticancer Drugs; 2007 Mar; 18(3):323-32. PubMed ID: 17264766
[TBL] [Abstract][Full Text] [Related]
22. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of cytotoxicity of selected organogold(III) compounds.
Coronnello M; Mini E; Caciagli B; Cinellu MA; Bindoli A; Gabbiani C; Messori L
J Med Chem; 2005 Oct; 48(21):6761-5. PubMed ID: 16220992
[TBL] [Abstract][Full Text] [Related]
25. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
[TBL] [Abstract][Full Text] [Related]
26. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
[TBL] [Abstract][Full Text] [Related]
27. Solution chemistry and cytotoxic properties of novel organogold(III) compounds.
Messori L; Marcon G; Cinellu MA; Coronnello M; Mini E; Gabbiani C; Orioli P
Bioorg Med Chem; 2004 Dec; 12(23):6039-43. PubMed ID: 15519149
[TBL] [Abstract][Full Text] [Related]
28. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action.
Gouvea LR; Garcia LS; Lachter DR; Nunes PR; de Castro Pereira F; Silveira-Lacerda EP; Louro SR; Barbeira PJ; Teixeira LR
Eur J Med Chem; 2012 Sep; 55():67-73. PubMed ID: 22835721
[TBL] [Abstract][Full Text] [Related]
29. N(4)-tolyl-2-acetylpyridine thiosemicarbazones and their platinum(II,IV) and gold(III) complexes: cytotoxicity against human glioma cells and studies on the mode of action.
Ferraz KS; Da Silva JG; Costa FM; Mendes BM; Rodrigues BL; dos Santos RG; Beraldo H
Biometals; 2013 Oct; 26(5):677-91. PubMed ID: 23749148
[TBL] [Abstract][Full Text] [Related]
30. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
Wang X; Guo Z
Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
32. Structure and properties of neutral and cationic gold(III) complexes from substituted 2-(2'-pyridyl)quinoline ligands.
Laguna EM; Olsen PM; Sterling MD; Eichler JF; Rheingold AL; Larsen CH
Inorg Chem; 2014 Dec; 53(23):12231-3. PubMed ID: 25390894
[TBL] [Abstract][Full Text] [Related]
33. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
34. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
[TBL] [Abstract][Full Text] [Related]
35. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.
Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN
Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331
[TBL] [Abstract][Full Text] [Related]
36. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
Lee PK; Law WH; Liu HW; Lo KK
Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
[TBL] [Abstract][Full Text] [Related]
37. Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme.
Bertrand B; Spreckelmeyer S; Bodio E; Cocco F; Picquet M; Richard P; Le Gendre P; Orvig C; Cinellu MA; Casini A
Dalton Trans; 2015 Jul; 44(26):11911-8. PubMed ID: 26060937
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
39. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, structure and cytotoxicity studies of diisopropylammonium and triethylammonium salts of triphenylphosphinegold(I) sulfanylcarboxylates.
Barreiro E; Casas JS; Couce MD; Sánchez A; Sánchez-González A; Sordo J; Varela JM; López EM
J Inorg Biochem; 2009 Jul; 103(7):1023-32. PubMed ID: 19501912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
